MoonLake Immunotherapeutics
MLTX
NASDAQ·Healthcare·Biotechnology·Mkt cap $1.3B
$15.19
▲ +0.86%
P/E
-3.95
Mkt Cap
$1.3B
52-Wk Range
$5.95–$62.75
52-Week Range
$5.95 - $62.75
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 74.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Novel Nanobody technology platform with differentiation from traditional antibodies
- Strategic focus on high-prevalence inflammatory indications with significant market potential
- Clinical-stage asset with multiple Phase II programs reducing single-asset risk
- Swiss headquarters providing access to advanced biotech talent and regulatory expertise
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Phase II trial progression and potential positive clinical data readouts
Value
Deep value opportunity - significant discount to sector peers
Momentum
Weak
-17.6% over 3m
Quality
Loss-making
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying MLTX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 10, 2026
Reported EPS of -$0.84 vs -$0.91 consensus (+7.5% surprise).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+7.5%
Revenue trend · last 8Q
—
—
—
—
—
—
—
—
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$0
$0
$0
$0
$0
$0
$0
$0
Margins · last 8Q
No margin history available.
Wall Street consensus
6 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: HC Wainwright · Aug 13, 2026
vs Industry
How MLTX stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.